Learn the latest in cancer care, anywhere
Binaytara is a leading global oncology nonprofit that organizes the most CME-accredited cancer conference in US. Binaytara has impacted thousands of oncology/hematology professionals since 2007. Now we are bringing that collective knowledge to you through a game-changing app - OncoBlast.
Claim ABIM MOC points and/or AMA PRA Category 1 Credit™ and CME credits for free.
Improve your cancer care from questions and explanations created and reviewed by leading oncologists.
Learn through game-based educational activities that enhance engagement and knowledge retention.
Global Knowledge Ranking
The global leaderboard shows you how your medical knowledge stacks up against other physicians and healthcare providers around the world.
Comprehensive Oncology Curriculum
Track your progress. New courses and questions are added weekly. See how many courses you can ace!
Our Courses
Developing an educational game aimed at healthcare providers to immerse them in the forefront of oncology advancements.
OncoBlast-Clinical Decisions in Lymphoid Cancers: Real-World Case Insights
This CME-accredited OncoBlast activity uses case-based questions to explore evolving treatment strategies in B-cell lymphomas, CLL, and Hodgkin lymphoma. Each interactive scenario is grounded in current clinical trials and guideline updates for practical, evidence-based learning.
OncoBlast-Personalized Lung Cancer Care: Updates on Efficacy, Toxicity, and Clinical Decision-Making
This CME-accredited OncoBlast activity uses gamified, case-based questions to reinforce key updates in the management of advanced non-small cell lung cancer (NSCLC). Topics include biomarker-driven therapies (EGFR, ALK, MET, BRAF, KRAS, HER2), treatment sequencing, and toxicity management. Learners will apply evidence-based strategies to real-world scenarios and stay current with the latest approvals and guidelines in precision oncology.
OncoBlast-Best of Hematology and Breast Cancer II
This CME-accredited activity, Best of Hematology and Breast Cancer II, is designed to offer practical insights into hematology and breast cancer care by educating clinicians involved in cancer care. This activity is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care of breast cancer.
What Our Doctors Are Saying
Dive deep into the world of oncology with our quiz questions meticulously crafted and reviewed by leading oncology faculty members. Topics include cancer biology, diagnosis, treatment modalities, and patient care.
As a busy physician, staying updated with the latest medical knowledge is crucial. This Quiz App not only challenges my understanding....
Dr. Ulka Vaishampayan, MD
University of Michigan Rogel Cancer Center
"I can't thank the creators of this app enough for developing such a valuable learning tool. It‘s not just a learning tool; it's a source of inspiration that motivates me to strive for excellence in my practice."
Dr. Mridula Krishnan, MD
Oncologist, University of Nebraska Medical Center
OncoBlast is a visual way of gaining knowledge and makes learning fun and interesting! It is an innovative platform to disseminate knowledge on the recent advances in the field, helping improve patient outcomes by helping physicians stay up to date with the evolving literature.
Dr. Shripa Gandhi
Roswell Park Comprehensive Cancer Center
Gaming and Learning! You can do both at the same time.
Dr. Lei Deng
University of Washington, Fred Hutchinson Cancer Center
OncoBlast
Making OncoBlast Worldwide!
Join the global community of oncology professionals, enhance your knowledge, and make a difference in the world of cancer care. Binaytara is dedicated to improving healthcare by providing innovative educational tools and opportunities for healthcare professionals worldwide. OncoBlast represents a significant advancement in medical education, blending easy global access and engaging entertainment in a way that has never been done before with cancer CME.
